Company page

Virax Biolabs Group Limited

Virax Biolabs Group Limited, trading under the ticker VRAX, is a public company based in the United States with a market capitalization of approximately $2.54 million. The company focuses on developing and commercializing innovative solutions in the healthcare sector. Virax aims to address various medical challenges through its research and product offerings.